This content is from: Premium Hedge Funds Went Bottom Fishing and Found These Gems Several hedge funds, including Melvin, Adage and EcoR1, have made some potentially savvy buys in the past few weeks. By Steve Taub April 01, 2020
This content is from: Premium These Hedge Funds Held a Big Monday Winner At least three hedge funds were among the top shareholders of a biopharma company that was up by double-digits amid the market’s meltdown. By Stephen Taub September 20, 2021
This content is from: Premium Hedge Funds Eye SPAC Mergers A large number of firms, including Viking, Millennium, Citadel and Magnetar, have sizable stakes in at least three deals scheduled to be completed this week. By Stephen Taub September 27, 2021
This content is from: Premium Hedge Funds Surface in Wave of Biopharma SPAC Deals RTW and Perceptive Advisors are among investors seen in recent SPAC deals in biopharma. By Stephen Taub October 19, 2020
This content is from: Research Corporate Access in Asia Is More Accessible Than Ever, Thanks to These Top Firms After over a year of virtual programming, Morgan Stanley leads Asia’s Top Corporate Access Providers. By Alexandra DeLuca June 21, 2021
This content is from: Premium Meet Chamath Palihapitiya’s Obscure SPAC Partner Why the SPAC-dealmaker is teaming up with Suvretta to launch four blank check companies. By Stephen Taub June 04, 2021
